BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Immunology - Infectious Diseases - Microbiology - Pediatrics and Child Health

Age-Related Differences in Naturally Acquired T Cell Memory to Plasmodium falciparum Merozoite Surface Protein 1
Published: Friday, September 16, 2011
Author: Kiprotich Chelimo et al.

by Kiprotich Chelimo, Paula B. Embury, Peter Odada Sumba, John Vulule, Ayub V. Ofulla, Carole Long, James W. Kazura, Ann M. Moormann

Naturally acquired immunity to Plasmodium falciparum malaria in malaria holoendemic areas is characterized by the gradual, age-related development of protection against high-density parasitemia and clinical malaria. Animal studies, and less commonly, observations of humans with malaria, suggest that T-cell responses are important in the development and maintenance of this immunity, which is mediated primarily by antibodies that slow repeated cycles of merozoites through erythrocytes. To advance our rather limited knowledge on human T-cell immunity to blood stage malaria infection, we evaluated CD4 and CD8 T-cell effector memory subset responses to the 42 kDa C-terminal fragment of Merozoite Surface Protein 1 (MSP142), a malaria vaccine candidate, by 49 healthy 0.5 to =18 year old residents of a holoendemic area in western Kenya. The proportion of individuals with peripheral blood mononuclear cell MSP142 driven IFN-? ELISPOT responses increased from 20% (2/20) among 0.5–1 year old children to 90% (9/10) of adults =18 years (P?=?0.01); parallel increases in the magnitude of IFN-? responses were observed across all age groups (0.5, 1, 2, 5 and =18 years, P?=?0.001). Less than 1% of total CD4 and CD8 T-cells from both children and adults produced IFN-? in response to MSP142. However, adults had higher proportions of MSP142 driven IFN-? secreting CD4 and CD8 effector memory (CD45RA- CD62L-) T-cells than children (CD4: 50.9% vs. 28.8%, P?=?0.036; CD8: 52.1% vs. 18.3%, respectively P?=?0.009). In contrast, MSP142 driven IFN-? secreting naïve-like, transitional (CD45RA+ CD62L+) CD4 and CD8 cells were the predominant T-cell subset among children with significantly fewer of these cells in adults (CD4: 34.9% vs. 5.1%, P?=?0.002; CD8: 47.0% vs. 20.5%, respectively, P?=?0.030). These data support the concept that meaningful age-related differences exist in the quality of T-cell immunity to malaria antigens such as MSP1.
  More...

 

//-->